🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to id transarterial chemoembolization (TACE) ...
Status
Unknown
Location
Zhongda Hospital, Southeast University
Start Date
2022-04-01
Trial ID
NCT05278195
Hepatocellular Carcinoma (HCC) is a primary liver cancer. It is the 6th mos...
Status
Unknown
Location
King Faisal Specilist Hopsital & Researchc Center
Start Date
2016-01
Trial ID
NCT02729506
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of N...
Status
Active Not Recruiting
Location
Fujian Cancer Hospital
Start Date
2025-04-15
Trial ID
NCT06900543
Treatments Being Tested
Transarterial chemoembolization (TACE) is widely used for unresectable hepa...
Status
Unknown
Location
Shandong Cancer Hospital and Institute
Start Date
2012-05
Trial ID
NCT01556815
Treatments Being Tested
The goal of this interventional study is to compare treatment response betw...
Status
Recruiting
Location
Department of Hepatology, Bangladesh Medical University
Start Date
2025-04-08
Trial ID
NCT07408804
Treatments Being Tested
This is a phase IB study design planned to identify the MTD (Maximum Tolera...
Status
Withdrawn
Location
The University of Michigan Comprehensive Cancer Center
Start Date
2017-07
Trial ID
NCT02997956
Treatments Being Tested
The survival of subjects with unresectable hepatocellular carcinoma (HCC) r...
Status
Completed
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2011-05-18
Trial ID
NCT01352728
Treatments Being Tested
RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow t...
Status
Completed
Location
Northwestern University, Northwestern Memorial Hospital
Start Date
2009-08
Trial ID
NCT00956930
Treatments Being Tested
Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-03-10
Trial ID
NCT03937830
Treatments Being Tested
Transcatheter arterial chemoembolization (TACE) is a key palliative treatme...
Status
Unknown
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2016-02
Trial ID
NCT02338297